Nu Skin Enterprises, Inc. (NUS) is up 24.34% today after raising its revenue estimates for Q2 up to $608 million. Analysts were estimating NUS Q2 revenue to be around $540 million. The stock is seeing a massive surge in price as investors react to the updated projections and increased optimism coming from Nu Skin Enterprise. The strength of sales during the pandemic is leading to improved overall market sentiment.
NUS stock is higher by 1.44% over the last 12 months, and the average rating from Wall Street analysts is a Sell. InvestorsObserver’s proprietary scoring system, gives NUS stock a score of 47 out of a possible 100.
That score is primarily influenced by a fundamental score of 5. In addition to the average rating from Wall Street analysts, NUS stock has a mean target price of 34.333. This means analysts expect the stock to decrease 28.19% over the next 12 months. NUS’s score also includes a short-term technical score of 59. The long-term technical score for NUS is 77.
What’s Happening with NUS Stock Today
Nu Skin Enterprises, Inc. (NUS) stock is higher by 24.34% while the S&P 500 is higher by 1.33% as of 10:21 AM on Thursday, Jul 2. NUS is higher by $9.36 from the previous closing price of $38.45 on volume of 907,248 shares. Over the past year the S&P 500 has gained 5.39% while NUS is higher by 1.44%. NUS earned $2.69 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 17.63.
